当前位置: X-MOL 学术Eur. J. Heart Fail. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Baroreflex activation therapy in patients with heart failure and a reduced ejection fraction: Long-term outcomes
European Journal of Heart Failure ( IF 18.2 ) Pub Date : 2024-04-12 , DOI: 10.1002/ejhf.3232
Michael R. Zile 1 , JoAnn Lindenfeld 2 , Fred A. Weaver 3 , Faiez Zannad 4 , Elizabeth Galle 5 , Tyson Rogers 6 , William T. Abraham 7
Affiliation  

Carotid baroreflex activation therapy (BAT) restores baroreflex sensitivity and modulates the imbalance in cardiac autonomic function in patients with heart failure with reduced ejection fraction (HFrEF). We tested the hypothesis that treatment with BAT significantly reduces cardiovascular mortality and heart failure morbidity and provides long-term safety and sustainable symptomatic improvement.

中文翻译:


射血分数降低的心力衰竭患者的压力感受反射激活疗法:长期结果



颈动脉压力反射激活疗法(BAT)可以恢复射血分数降低的心力衰竭(HFrEF)患者的压力反射敏感性并调节心脏自主功能的不平衡。我们测试了这样的假设:BAT 治疗可显着降低心血管死亡率和心力衰竭发病率,并提供长期安全性和可持续的症状改善。
更新日期:2024-04-12
down
wechat
bug